Abstract:Cancer remains a primary threat to human lives. Recently, amplification of tumor-associated reactive oxygen species (ROS) has been used as a boosting strategy to improve tumor therapy. Here, we report on a bone-targeting prodrug mesoporous silica-based nanoreactor for combined photodynamic therapy (PDT) and enhanced chemotherapy for osteosarcoma. Because of surface modification of a bone-targeting biphosphate moiety and the enhanced permeability and retention effect, the formed nanoreactor shows efficient accumulation in osteosarcoma and exhibits long-term retention in the tumor microenvironment. Upon laser irradiation, the loaded photosensitizer chlorin e6 (Ce6) produces in situ ROS, which not only works for PDT but also functions as a trigger for controlled release of doxorubicin (DOX) and doxycycline (DOXY) from the prodrugs based on a thioketal (<i>TK</i>) linkage. The released DOXY further promotes ROS production, thus perpetuating subsequent DOX/DOXY release and ROS burst. The ROS amplification induces long-term high oxidative stress, which increases the sensitivity of the osteosarcoma to chemotherapy, therefore resulting in enhanced tumor cell inhibition and apoptosis. The as-developed nanoreactor with combined PDT and enhanced chemotherapy based on ROS amplification shows significant promise as a potential platform for cancer treatment.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsami.0c08992?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsami.0c08992</a>.1H NMR spectra of TK, DOX-TK, and DOX-TK-DOXY; inverted fluorescence microscopy images and cell apoptosis with TUNEL staining and cell cycle analyses of OS-732 cells; loading contents of Ce6 for /MSN/DOX-TK-DOXY; particle size, UV-vis absorption spectra, and DOX and DOXY release profiles of /MSN/DOX-TK-DOXY; phototriggered intracellular DOX and DOXY release; intracellular ROS production in OS-732 cells; cell apoptosis with TUNEL staining of OS-732 cells treated with /MSN/DOX-TK-DOXY; MTP measurements for /MSN/DOX-TK-DOX; OS-732 cell metabolism after different treatments; body weights of mice bearing OS-732 tumors; ROS analysis in tumor tissues after treatment with /MSN/DOX-TK-DOXY; inner ring tumor microvessel tortuosity and density; HE staining of main organs after treatment; CD31 expression and RT-PCR analyses of tumor vessels; and quantification of DOX and DOXY contents in major organs (<a class="ext-link" href="/doi/suppl/10.1021/acsami.0c08992/suppl_file/am0c08992_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Enhanced Osteosarcoma Immunotherapy via CaCO3 Nanoparticles: Remodeling Tumor Acidic and Immune Microenvironment for Photodynamic Therapy (Adv. Healthcare Mater. 23/2024)

Unique Photochemo-Immuno-Nanoplatform Against Orthotopic Xenograft Oral Cancer and Metastatic Syngeneic Breast Cancer.

Biomimetic Metallacage Nanoparticles with Aggregation-Induced Emission for NIR-II Fluorescence Imaging-Guided Synergistic Immuno-Phototherapy of Tumors

Enhancing Osteosarcoma Killing and CT Imaging Using Ultrahigh Drug Loading and NIR-Responsive Bismuth Sulfide@Mesoporous Silica Nanoparticles

Oligopeptide modified ICG/Cisplatin@CaCO 3 for targeted osteosarcoma NIR-II imaging guided multimodal therapy

Integration of gold nanodendrites and immune checkpoint blockers to achieve highly efficient photothermal immunotherapy for eradicating primary and distant metastatic osteosarcoma

Photothermally Reinforced Chemodynamic Therapy in the Treatment of Osteosarcoma by Polydopamine-Modified, Copper Peroxide Loaded ZIF8 Nanoparticles

Autophagy Inhibitor Enhance ZnPc/BSA Nanoparticle Induced Photodynamic Therapy by Suppressing PD-L1 Expression in Osteosarcoma Immunotherapy.

Photothermal-Triggered Extracellular Matrix Clearance and Dendritic Cell Maturation for Enhanced Osteosarcoma Immunotherapy

Capsaicin Enhanced the Efficacy of Photodynamic Therapy Against Osteosarcoma via a Pro‐Death Strategy by Inducing Ferroptosis and Alleviating Hypoxia

Homologous targeting nanoparticles for enhanced PDT against osteosarcoma HOS cells and the related molecular mechanisms

Hyaluronate-Based Self-Stabilized Nanoparticles for Immunosuppression Reversion and Immunochemotherapy in Osteosarcoma Treatment

Bone-Targeting Prodrug Mesoporous Silica-Based Nanoreactor with Reactive Oxygen Species Burst for Enhanced Chemotherapy

Engineering PDA-coated CM-CS nanoparticles for photothermo-chemotherapy of osteosarcoma and bone regeneration

A multifunctional CaCO3 bioreactor coated with coordination polymers enhances cancer immunotherapy

Biomimetic Targeted Co‐Delivery System Engineered from Genomic Insights for Precision Treatment of Osteosarcoma

Recent advances in nanoagents delivery system-based phototherapy for osteosarcoma treatment

Microalgae-based Drug Delivery System for Tumor Microenvironment Photo-Modulating and Synergistic Chemo-Photodynamic Therapy of Osteosarcoma

Laser/GSH-Activatable Oxaliplatin/Phthalocyanine-Based Coordination Polymer Nanoparticles Combining Chemophotodynamic Therapy to Improve Cancer Immunotherapy

CPPs-modified chitosan as permeability-enhancing chemotherapeutic combined with gene therapy nanosystem by thermosensitive hydrogel for the treatment of osteosarcoma

Intracellular Co-delivery of proteins and chemotherapeutics using calcium carbonate mineralized nanoparticles for osteosarcoma therapy